{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:39:07Z","timestamp":1767915547124,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":526,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jchf.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T21:38:11Z","timestamp":1463002691000},"page":"749-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Importance of Worsening Heart\u00a0Failure in Ambulatory Patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Aditi","family":"Mallick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul U.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna K.","family":"Gaggin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrien","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2016.03.012_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jama.2014.6643","article-title":"Recognizing worsening chronic heart failure as an entity and an end point in clinical trials","volume":"312","author":"Butler","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"h411","DOI":"10.1136\/bmj.h411","article-title":"Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study","volume":"350","author":"Dharmarajan","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","article-title":"Repeated hospitalizations predict mortality in the community population with heart failure","volume":"154","author":"Setoguchi","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2016.03.012_bib4","first-page":"65","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2016.03.012_bib6","first-page":"395","article-title":"Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF Studies","volume":"3","author":"Davison","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ahj.2010.01.005","article-title":"Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"159","author":"Bhardwaj","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurjhf\/hfs180","article-title":"Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study","volume":"15","author":"Weiner","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2016.03.012_bib11","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCHEARTFAILURE.113.000457","article-title":"Soluble concentrations of the interleukin receptor family member ST2 and \u03b2-blocker therapy in chronic heart failure","volume":"6","author":"Gaggin","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2016.03.012_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurjhf\/hft075","article-title":"Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"15","author":"Motiwala","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hfc.2012.09.002","article-title":"End points for comparative effectiveness research in heart failure","volume":"9","author":"Allen","year":"2013","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jchf.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamainternmed.2015.0315","article-title":"Primary results of the Patient-Centered Disease Management (PCDM) for Heart Failure Study: a randomized clinical trial","volume":"175","author":"Bekelman","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jchf.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a\u00a0critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jchf.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ahj.2012.08.015","article-title":"Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"164","author":"Bhardwaj","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/chf.12016","volume":"19","author":"Gaggin","year":"2013","journal-title":"Congest Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177916300816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177916300816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T03:59:10Z","timestamp":1536724750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177916300816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213177916300816"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2016.03.012","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Importance of Worsening Heart\u00a0Failure in Ambulatory Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}